| 1601 |
ALIGIRITINIB |
GILTERITINIB FUMARATE 40 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WHO HAVE RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA WITH AN FMS-LIKE TYROSINE KINASE 3 MUTATION |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
11 L 1234/24 |
14-NOV-2024 |
13-NOV-2029 |
View |
| 1602 |
ALIGLIBEN |
GLIBENCLAMIDE 5 MG |
TABLET |
BLISTERPACK |
TREATMENT OF DIABETE MELLITUS TYPE 2 |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
03 L 1082/24 |
08-APR-2024 |
07-APR-2027 |
View |
| 1603 |
ALIHAIRS |
FINASTERIDE 1 MG |
TABLET |
BOTTLE |
TREATMENT OF ANDROGENETIC ALOPECIA IN COMBINATION WITH MINOXIDIL, WHICH PROMOTES HAIR GROWTH AND PREVENTS CONTINUED HAIR LOSS |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
03 L 1077/24 |
14-MAR-2024 |
13-MAR-2027 |
View |
| 1604 |
ALIHYDROCORTISONE |
HYDROCORTISONE 10 MG |
FILM COATED TABLET |
BLISTERPACK |
PRIMARILY USED AS AN ALTERNATIVE TREATMENT FOR ADRENOCORTICAL INSUFFICIENCY AND CONGENITAL ADRENAL HYPERPLASIA.
ALSO USED TO TREAT RHEUMATIC DISORDERS, COLLAGEN DISEASES, EYE INFLAMMATION, GOUT, BRONCHIAL ASTHMA, SEVERE ALLERGIES, AND TREATMENT OF SEPTIC SHOCK.
|
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
08 L 1175/24 |
28-AUG-2024 |
27-AUG-2027 |
View |
| 1605 |
ALIIVOSIDENIB |
IVOSIDENIB 250 MG |
TABLET |
BOTTLE |
NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA, RECURRENT OR REFRACTORY ACUTE MYELOID LEUKEMIA, BILE DUCT CANCER |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
07 L 1130/24 |
12-JUL-2024 |
11-JUL-2027 |
View |
| 1606 |
ALIJI-3 |
SOFOSBUVIR 400 MG, VELPATASVIR 100 MG |
TABLET |
BOTTLE |
TREATMENT OF HEPATITIS C IN ADULT AND CHILDREN 3 YEARS AND OLDER |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
06 L 1125/24 |
01-JUL-2024 |
31-JUN-2027 |
View |
| 1607 |
ALILAROTINIB |
LAROTRECTINIB SULFATE 100 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF ADULT AND PEDIATRIC PATIENTS WITH SOLID TUMORS THAT HAVE A NEUROTROPHIC RECEPTOR TYROSINE KINASE GENE FUSION WITHOUT A KNOWN ACQUIRED RESISTANCE MUTATION, PATIENTS WITH LOCALLY ADVANCED, METASTATIC DISEASE, OR SURGICAL RESECTION THAT MAY LEAD TO SERIOUS COMPLICATION |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
11 L 1228/24 |
14-NOV-2024 |
13-NOV-2029 |
View |
| 1608 |
ALILEVO |
LEVONORGESTREL 1.5 MG |
TABLET |
BLISTERPACK |
FOR FEMALE EMERGENCY CONTRACEPTION, WHEN THERE ARE NO PROTECTIVE MEASURES OR OTHER CONTRACEPTIVE METHODS ARE ACCIDENTALLY WRONG |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
07 L 1129/24 |
12-JUL-2024 |
11-JUL-2027 |
View |
| 1609 |
ALILINAGLIPTIN |
LINAGLIPTIN 5 MG |
TABLET |
BLISTERPACK |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
08 L 1174/24 |
28-AUG-2024 |
27-AUG-2027 |
View |
| 1610 |
ALILOPERA |
LOPERAMIDE HYDROCHLORIDE 2MG |
CAPSULE |
BLISTERPACK |
FOR THE SYMPTOMATIC TREATMENT OF ACUTE DIARRHEA IN ADULTS AND CHIDREN AGED 12 YEARS AND OVER |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
11 L 1257/24 |
25-DEC-2024 |
24-DEC-2029 |
View |
